Skip to main content

and
  1. No Access

    Article

    TOXICAN: a guide for grading dermatological adverse events of cancer treatments

    The dermatological toxicity of cancer treatments is frequent and sometimes debilitating. Its reference classification, the NCI-CTCAE (National Cancer Institute–Common Terminology Criteria for Adverse Events), ...

    L. Peuvrel, J. Cassecuel, C. Bernier, G. Quéreux in Supportive Care in Cancer (2018)

  2. No Access

    Article

    Development of brain metastases in patients with metastatic melanoma while receiving ipilimumab

    Ipilimumab is a monoclonal antibody blocking the inhibitory molecule CTLA4 expressed by activated T lympocytes, used for the treatment of metastatic melanoma. Recent studies have shown its potential efficacy o...

    C. Frenard, L. Peuvrel, M. Saint Jean, A. Brocard, A. C. Knol in Journal of Neuro-Oncology (2016)